HACKENSACK, N.J., April 4, 2018 /PRNewswire/ -- Champions
Oncology, Inc. (Nasdaq: CSBR), engaged in the development of
advanced technology solutions and services to personalize the
development and use of oncology drugs, today announced that
management will be presenting at this year's MicroCap Conference on
Tuesday, April 10, 2018 at
9:30am.
The MicroCap Conference will take place in New York City at
the Essex House on April 9th and
10th. Registration will begin on Monday at 7:00AM and will last until the evening. These
days will be jam-packed with company presentations, 1-on-1
meetings, roundtables, expert panel discussions, and plenty of time
to network with other investors over food and drinks.
REGISTRATION FOR INVESTORS
To request free registration, please go to our website
(www.microcapconf.com), and click the "Registration" button
PARTICIPATING COMPANIES
For our most updated list of companies, please go to our website
(www.microcapconf.com)
News Compliments of ACCESSWIRE
FOR MORE INFORMATION
Please visit: www.microcapconf.com
Or, contact Tony Yu, CEO at
tony@microcapconf.com
About Champions Oncology, Inc.
Champions Oncology, Inc. is engaged in the development of
advanced technology solutions and services to personalize the
development and use of oncology drugs. The Company's TumorGraft
technology platform is a novel approach to personalizing cancer
care based upon the implantation of primary human tumors in immune
deficient mice followed by propagation of the resulting
engraftments, or TumorGrafts, in a manner that preserves the
biological characteristics of the original human tumor in order to
determine the efficacy of a treatment regimen. The Company
uses this technology in conjunction with related services to offer
solutions for two customer groups: Personalized Oncology
Solutions, in which results help guide the development of
personalized treatment plans, and Translational Oncology Solutions,
in which pharmaceutical and biotechnology companies seeking
personalized approaches to drug development can lower the cost and
increase the speed of developing new drugs. TumorGrafts are
procured through agreements with a number of institutions in the
U.S. and overseas as well as through Champions' Personalized
Oncology Solutions business. For more information, please visit
www.championsoncology.com.
View original
content:http://www.prnewswire.com/news-releases/champions-oncology-to-present-at-the-microcap-conference-on-april-10th-in-new-york-city-at-the-essex-house-300623804.html
SOURCE Champions Oncology, Inc.